The Antitumor Effect of MX2, a New Morpholino Anthracycline, against Malignant Glioma Cell Lines and Its Subcellular Distribution-Reference-Cited by-同舟云学术

The Antitumor Effect of MX2, a New Morpholino Anthracycline, against Malignant Glioma Cell Lines and Its Subcellular Distribution

Published:1995-09-01 Issue:3 Volume:37 Page:471-477
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Kabuto Masanori¹,Kubota Toshihiko¹,Kobayashi Hidenori¹,Nakagawa Takao¹,Kitai Ryuhei¹

Affiliation:

1. Department of Neurosurgery, Fukui Medical School, Fukui, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/37/3/471/24607215/0006123-199509000-00015.pdf

Reference18 articles.

1. Intensely potent morpholinyl anthracyclines;Acton;J Med Chem,1984

2. Efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule;Benjamin;Cancer,1974

3. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas;Bodell;Cancer Res,1985

4. The clinical evaluation of analogs: III–Anthracyclines;Carter;Cancer Chemother Pharmacol,1980

5. Daunorubicin and adriamycin in cancer treatment: An analysis of their roles and limitations;Davis;Cancer Treat Rep,1979

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring;Nuclear Medicine and Biology;2006-01

2. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model;International Journal of Hyperthermia;2004-09

3. Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: A comparative analysis using rodent models of gliomas;Neurological Research;2000-12

4. Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo;Journal of Neuro-Oncology;2000

5. Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients;Journal of Neuro-Oncology;2000